4853509 Health, Department of: Notice of Public Hearing by the Medical Marijuana Scientific Subcommittee to consideradding Post-Traumatic Stress Disorder as a New Qualifying Medical Condition
-
DEPARTMENT OF HEALTH
NOTICE OF PUBLIC HEARING
The Director of the Department of Health hereby gives the following notice pursuant to § 405 of the District of Columbia Health Occupation Revision Act of 1985, effective March 25, 1986 (D.C. Law 6-99; D.C. Official Code § 3-1204.05 (b)) (2009); Section 14 of the Legalization of Marijuana for Medical Treatment Amendment Act of 2010 (Act), effective July 27, 2010 (D.C. Law 18-210; D.C. Official Code §§ 7-1671.01, et seq. (2012 Supp.)), and Mayor’s Order 2013-201, dated October 28, 2013.
The District of Columbia Medical Marijuana Scientific Subcommittee of the Medical Marijuana Advisory Committee will hold a public hearing to consider adding Post-Traumatic Stress Disorder as a new qualifying medical condition. The public hearing will be held on:
Wednesday May 7, 2014, at 9:30 a.m.
At 899 North Capitol St, NE, Room 406/407
Washington, D.C. 20002
Any person that wishes to testify or present information in support of or in opposition to the inclusion of Post-Traumatic Stress Disorder as a qualifying medical condition may sign up by emailing his/her name and contact information to doh.mmp@dc.gov before 4:30 p.m. on Monday, May 5, 2014. Any person, who has not signed up by Monday, May 5, 2014, may still testify at the end of the hearing, time permitting. Any person may also submit written comment to the Scientific Subcommittee regarding the subject of this notice along with any documentation he/she would like the Subcommittee to consider. Written comment may be submitted beginning Monday, April 14, 2014 until 4:45pm on May 6, 2014.
The public hearing will be followed by an executive (closed) session meeting of the Scientific Subcommittee pursuant to D.C. Official Code § 2-575(b), and for the purposes set forth therein.
Questions regarding this Notice should be e-mailed to doh.mmp@dc.gov with “MMP-HEARING Question” in the subject line. Please monitor the Department’s Medical Marijuana website for questions/responses and other information. Phone inquiries will not be accepted.
